Nanomol Technologies announced this January the start of a European project, the Horizon Europe NABIHEAL project, by the hand of the Center for Biomedical Research Network (CIBER) of the Institut de Ciencia de Materiales de Barcelona (ICMAB-CSIC) as coordinator. The company, member of CataloniaBio & HealthTech, participates in the biomaterials scalie up tasks and co-lead the Business Development & Exploitation work package together with Histocell SL.
NABIHEAL stands for "Antimicrobial Nanostructured Biomaterials for Complex Wound Healing" and aims to solve two unmet medical needs in complex wound healing: affordable treatments for wound infections and prevention of complications during healing; and a strategy to optimize the composition and efficacy of wound dressings.
The NABIHEAL project wants to advance the synthesis of advanced biomaterials as an alternative to commonly used silver-based materials. The most common antimicrobial products for treating microbial infections are silver-based. However, they have several economic, environmental and safety drawbacks.
The project aims to obtain innovative multifunctional biomaterials for wound healing using affordable EU-based manufacturing technologies. In the long term, NABIHEAL could become a revolutionary alternative to silver in wound healing dressings. The project was launched on January 11-12, 2023 in Barcelona with the first meeting of the international consortium, formed by 14 partners from 7 countries, including research centres, universities and private companies.
Comments